The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow at a 10% CAGR from 2023 to 2033. The rising incidence of autoimmune disorders, such as rheumatoid arthritis, lupus, and multiple sclerosis, is fueling …
Category Archives: Healthcare Trends
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Targeting US$ 185 Million by 2033| Future Market Insights,Inc.
The market for ESR1 Mutated Metastatic Breast Cancer Diagnostics was valued at US$ 58.70 million in 2022 and is projected to grow at a CAGR of 11% to reach US$ 185 million from 2023 to 2033. The market for ESR1 mutated metastatic breast cancer diagnostics is expanding as a result of rising breast cancer incidence and the …
Small-Scale Bioreactors Market Aims for US$7.71 Billion by 2033| Future Market Insights,Inc.
The Small-scale Bioreactors Market By 2033, the market is expected to be worth US$ 7.71 billion. The market is expected to grow at a CAGR of 14.8% over the forecast period. FMI estimates the market to be worth US$ 1.94 billion in 2023. New therapies are expected to be increasingly developed in the coming years due to …
Vascular Dementia Treatment Market Envisioned to Reach US$ 8.99 Billion by 2033| Future Market Insights,Inc.
The estimated growth for the vascular dementia treatment market, according to a recent research by Future Market Insights, suggests an increase in market value to US$ 5.64 billion in FY 2023, showing a year-over-year rise of over 5%. Furthermore, over the projection period from 2023 to 2033, the market is anticipated to expand at a …
Clinical Next-Generation Sequencing (NGS) Data Analysis Market is poised for growth, with an expected valuation of US$ 13.1 billion by 2033, as reported by FMI
As per Future Market Insights’ latest industry analysis, the valuation for the global Clinical Next-Generation Sequencing (NGS) Data Analysis Market was around US$ 2.3 Billion in 2022, and the market is projected to exhibit growth at a CAGR of 17.4% over the forecast period, with an estimated valuation of around US$ 13.1 Billion by 2033. …
Global Prophy Dental Handpiece Market is expected to surge to US$ 398.8 Million by 2033 | FMI
By the end of 2023, the global Prophy Dental Handpiece Market is anticipated to have a value of US$ 229.3 million, and it will grow at a CAGR of 5.7% to reach US$ 398.8 million by the year 2033. Electric-driven prophy dental handpieces are anticipated to hold the majority of the market in 2023, with …
Generalized Anxiety Disorder Treatment Market is on the upswing, set to grow at a 9% CAGR by 2033 | FMI
The generalized anxiety disorder treatment market is projected to reach a market size of US$ 1800 million in 2023 and US$ 4261.25 million by 2033, growing at a CAGR of 9% over that time. The market for treating generalised anxiety disorder is expanding due to the rising incidence of mental health issues and the wide …
Salivary Gland Infection Treatment Market is poised to hit US$ 12,300 Million in value by 2033, according to a study by FMI
The Salivary Gland Infection Treatment Market is anticipated to reach a market size of US$ 5054.79 million in 2023 and US$ 12,300 million by 2033, with a CAGR of 9.3%. The rising incidence of salivary gland infections and the accessibility of pharmaceuticals to treat the condition are both factors contributing to the growth of the …
Sandhoff Disease Therapeutics Market is estimated to exhibit a 6% CAGR, bringing its value to US$ 17.91 Million by 2033, according to FMI
According to a recent study published by Future Market Insights, the sandhoff disease therapeutics market is slated to experience noteworthy expansion. The market for Sandhoff disease therapeutics is forecast to accumulate a market value of US$ 10 million by 2023-end, and will ultimately reach a valuation of US$ 17.91 million by 2033. Registering a CAGR …
Brain Tumor Drugs Market is advancing steadily and is expected to reach US$ 6.30 Billion by 2033 | FMI
The market for pharmaceuticals used to treat brain tumors is known as the ” Brain Tumor Drugs Market,” and it is a subset of the pharmaceutical business. Brain tumors are abnormal cell growths in the brain that may or may not be cancerous (benign) or malignant (cancerous). They can have a variety of symptoms and …